Skip to main content
CRL logo

Charles River Laboratories International, Inc.

CRLNYSEHealthcareDiagnostics & Research

$345.37Today:- (-)1Y +77.86%

As of Oct 23, 2026 close

Market cap
$16.59B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$146.20$333.30
Volume (live)
-
Avg. volume (3M)
1.09M

Charles River Laboratories International, Inc. (CRL) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Charles River Laboratories International, Inc. stock.

Analyst Consensus Rating

Investment consensus from 16 professional research analysts

Consensus Rating

Buy
Based on 16 unique analysts
(21 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$328.00
−5.03% downside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CRL Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Kallum Titchmarsh
Morgan Stanley
BuyMaintains
$300.00 → $340.00
Ryan Halsted
RBC Capital
BuyMaintains
$322.00
Kevin Caliendo
UBS
BuyInitiates
$357.00
David Windley
Jefferies
BuyMaintains
$305.00 → $340.00
Michael Ryskin
BofA Securities
BuyReiterates
-
Ann Hynes
Mizuho
HoldMaintains
$264.00 → $295.00
Justin Bowers
Deutsche Bank
BuyReiterates
$300.00 → $320.00
Eric Coldwell
Baird
BuyMaintains
$291.00 → $334.00
Ryan Halsted
RBC Capital
BuyMaintains
$282.00 → $322.00
Elizabeth Anderson CFA
Evercore ISI Group
BuyMaintains
$320.00 → $330.00
Jared Haase
William Blair
BuyReiterates
-
Luke Sergott
Barclays
BuyMaintains
$300.00 → $330.00
Kallum Titchmarsh
Morgan Stanley
BuyReiterates
$300.00
David Toung
Argus Research
BuyInitiates Coverage
$250.00 → $330.00
Abhinab Dasgupta
Zacks Equity Research
BuyInitiates Coverage
-
Sridatri Sarkar
Zacks Equity Research
BuyInitiates Coverage
-
Elizabeth Anderson CFA
Evercore ISI Group
BuyMaintains
$260.00 → $300.00
Jared Haase
William Blair
BuyReiterates
-
Casey Woodring
JP Morgan
BuyDowngrades
$180.00 → $310.00
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Ryan Halsted
RBC Capital
BuyMaintains
$215.00 → $282.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 12, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for CRL?

The analyst consensus rating for CRL is Buy, based on the latest ratings from 16 analysts over the last 90 days.

What is the average price target for CRL?

The average 12-month price target for CRL is $328.00, representing a downside of 5.0% from the Oct 23, 2026 close of $345.37.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.